{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:32:35Z","timestamp":1791268355605,"version":"4.1.0"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapeutic Drug Monitoring"],"published-print":{"date-parts":[[1986,6]]},"DOI":"10.1097\/00007691-198606000-00007","type":"journal-article","created":{"date-parts":[[2006,11,6]],"date-time":"2006-11-06T05:47:24Z","timestamp":1162792044000},"page":"166-171","source":"Crossref","is-referenced-by-count":27,"title":["Review of Alterations in Oral Phenytoin Bioavailability Associated with Formulation, Antacids, and Food"],"prefix":"10.1097","volume":"8","author":[{"given":"A. Timothy","family":"Cacek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007691-198606000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:08:10Z","timestamp":1786028890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-198606000-00007"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[1986,6]]},"references-count":0,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1097\/00007691-198606000-00007","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[1986,6]]}}}